Depression screening predicts subsequent disability progression in people with primary progressive multiple sclerosis.

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Positive interim Phase 1 data of NEK7-directed MGD MRT-8102 demonstrated profound CRP reductions in elevated CVD-risk subjects; readout of expanded part 3 CRP PoC trial (now called GFORCE-1) anticipat ...